Peter Brodersen is a Professor at the Department of Biology, University of Copenhagen , specializing in Bioinformatics and RNA Biology . His research focuses on RNA modification (m6A), YTHDF proteins, and small RNA pathways in plants. Recent research trends from his group include: (1) molecular mechanisms of ARGONAUTE-small RNA interactions, (2) m6A-YTHDF regulatory systems in plant development, and (3) RNAi-independent roles of DICER-LIKE proteins in antiviral defense. Collaborations span Denmark and international institutions. Publications highlight cross-disciplinary work bridging computational biology and experimental plant genetics. Key subfields include RNA structure, epigenetic regulation, and antiviral immunity.
Jens S. Andersen is a Professor in the Department of Biochemistry and Molecular Biology at the University of Southern Denmark, where he leads research in Biomedical Mass Spectrometry and Systems Biology. His work is centered on the development and application of quantitative mass spectrometry and microscopy-based proteomics to study human cell biology, particularly the structure and function of organelles such as centrosomes, cilia, autophagosomes, and mitochondria. His research focuses on determining the protein composition and dynamic properties of cellular organelles, the roles of specific protein groups, and their contributions to biological processes and diseases. He investigates cell signaling mediated by post-translational modifications, especially within the DNA damage response, autophagy, and immune systems. His lab, the Jens S. Andersen Lab, is part of the Research Section of Biomedical Mass Spectrometry. The analysis of his recent publications reveals a strong interdisciplinary trend combining proteomics, structural biology, and cell signaling. His work spans cilia biology, RNA metabolism, DNA repair, and cancer mechanisms, with frequent use of advanced techniques like mass spectrometry, CRISPR, and live-cell imaging. The integration of systems biology approaches is evident across his research outputs. Professor, Department of Biochemistry and Molecular Biology, University of Southern Denmark Head of Research, Biomedical Mass Spectrometry and Systems Biology Principal Investigator, Jens S. Andersen Lab ORCID: 0000-0002-6091-140X While no specific scientific awards are mentioned in the provided texts, his extensive publication record in high-impact journals such as Science , Nature Communications , Molecular Cell , and EMBO Journal reflects significant scholarly contributions. He has supervised research projects and collaborated widely across Europe, though specific names of students are not listed. His research is supported by multiple ongoing projects, reflecting sustained funding and academic leadership. The Jens S. Andersen Lab operates at the intersection of proteomics and cell biology, contributing to fundamental understanding of organelle dynamics and disease mechanisms. The lab's work is highly collaborative, involving partnerships with groups in structural biology, RNA research, and cancer biology.
Jeppe Lund Nielsen is a Professor in the Department of Chemistry and Life Sciences at the Faculty of Engineering and Science, Aalborg University, Denmark. His research lies at the intersection of microbial ecology, genomics, and environmental biotechnology, with a strong focus on sustainable solutions for wastewater treatment, anaerobic digestion, and environmental monitoring. His primary research interests include Microbial Ecology, Functional Ecology, Genomics, Molecular and Technical Microbiology, Anaerobic Digestion, Metagenomics, and eDNA Metabarcoding . He applies molecular tools to understand microbial community dynamics in engineered and natural systems, particularly in wastewater and marine environments. His work contributes to the UN Sustainable Development Goals related to clean water, sustainable cities, and climate action. The recent publication trends reflect a strong emphasis on environmental applications of microbiome science, including nitrogen cycling in wastewater, bioaerosol exposure in workers, eDNA-based biodiversity monitoring, and valorization of waste streams through biotechnology. His articles frequently appear in high-impact environmental and microbiological journals and demonstrate interdisciplinary collaboration across engineering, ecology, and public health. Among his notable scientific contributions are leadership roles in significant research projects such as the AAU Bubble Project (Power2Proteins), JAMBO seabed impact study, and investigations into biotechnological pesticides. He has also contributed to public discourse through media engagement on topics like pesticide regulation and environmental innovation. Professor Nielsen has supervised PhD students, including M. Eskeldsen, and is actively involved in grants and collaborative research across Europe. He is a key member of research teams focused on environmental microbiology, wastewater biotechnology, and marine impact assessments. His lab integrates molecular biology, bioinformatics, and environmental engineering to address pressing sustainability challenges.
Maria Timofeeva is an Associate Professor in the Epidemiology, Biostatistics and Biodemography (EBB) department at the University of Southern Denmark (SDU), with additional affiliation at the Danish Institute for Advanced Study (DIAS). She holds an Honorary Fellow position at the University of Edinburgh since December 2019. Her research focuses on cancer prevention and prediction, particularly studying the effects of environmental and genetic factors on cancer risk and progression. Dr. Timofeeva earned her Dr.sc.hum in Epidemiology from Heidelberg University (2005-2009), with a dissertation on genetic polymorphisms as risk factors for early onset lung cancer. Prior to her current position, she worked as a Statistical Geneticist at the University of Edinburgh (2013-2019) and as a Postdoctoral Fellow at the International Agency for Research on Cancer (2009-2013). Her research interests center around understanding the genetics of cancer risk through multi-omic analysis. She leads several significant projects, including the Interdisciplinary Project on Adherence to Colorectal Cancer Screening, meta-analysis of factors associated with false-positive and false-negative FOBT results (registered in PROSPERO ID: CRD42022315767), and the COlorectal Cancer screening Among RElatives (CoCARE) twin-family study in Denmark. Her methodological expertise spans observational epidemiological studies (case-control, population-based cohort studies, twin studies), meta-analysis, umbrella reviews, and multi-omics data analysis. Analysis of her recent publications reveals a strong focus on colorectal cancer genetics, with particular emphasis on genome-wide association studies, Mendelian randomization approaches, and trans-ancestry analyses. Her work frequently leverages large datasets including the UK Biobank and international consortia, with applications in cancer risk prediction and understanding gene-environment interactions. Dr. Timofeeva has an extensive publication record with 73 publications listed in her profile. Her research has been cited across multiple platforms, with mentions in news outlets, social media, and academic readership platforms like Mendeley. She is actively involved in academic service, serving as a peer reviewer for journals including BMC Cancer and Scientific Reports, and participating in conferences such as the 26th Nordic Congress of Gerontology. She also serves on evaluation committees, including with the World Cancer Research Fund International (April-May 2024). Her teaching activities include courses on evidence-based drug utilization and biostatistics, as well as supervision of research projects on gene expression in twins. Dr. Timofeeva has engaged with the public through media contributions, including an interview titled 'Jeg vil forstå, hvorfor vi får kræft' (November 15, 2021), where she discussed understanding why we get cancer.
Kunihiko Kaneko is a Professor at the Niels Bohr Institute, University of Copenhagen, with a distinguished career in theoretical biophysics and complex systems. He received his PhD and MSc in Physics from the University of Tokyo, and has held leadership roles at the Universal Biology Institute and Center for Complex Systems Biology. PhD Physics, 1984 - University of Tokyo MSc Physics, 1981 - University of Tokyo His research spans five primary areas: Universal Biology, Evolutionary Constraints, Ecosystem Dynamics, Neural Cognition, and Universal Anthropology. He has published extensively on multi-level consistency principles, dimensional reduction in biological systems, and reciprocity between robustness and plasticity across scales. Recent publications show strong focus on microbial ecosystems (2025), evolutionary game theory (2025), neural modular architectures (2024), and dimensional reduction in cellular systems (2024). His work bridges physics and biology through dynamical systems theory applied to diverse phenomena from protocells to human societies.
Yukiko Gotoh is a Professor at the Department of Pharmaceutical Sciences, Graduate School of Pharmaceutical Sciences, The University of Tokyo. She serves as the Deputy Director and Principal Investigator at the International Research Center for Neurointelligence (IRCN). Her research focuses on understanding the mechanisms that regulate neural stem/progenitor cell fate during embryonic brain development and in the adult brain. Dr. Gotoh's research interests include: Genetic and epigenetic regulation of neural stem/progenitor cell fate Neuronal maturation processes Genesis and maintenance of adult neural stem cells Relevance of neural stem/progenitor cell dysregulation in neurodevelopmental disorders such as autism spectrum disorders Investigation of mechanisms regulating neural stem-progenitor cell fate during neocortical development Genetic and epigenetic regulation of neuronal activation Analysis of Dr. Gotoh's recent publications reveals a strong focus on neural stem cell biology, epigenetic regulation, and neurodevelopmental disorders. Her work demonstrates how chromatin modifiers like Polycomb group proteins and HMGA proteins regulate neural stem cell fate decisions during brain development. A significant portion of her research explores the embryonic origins of adult neural stem cells and how dysregulation of these processes contributes to conditions like autism spectrum disorders and schizophrenia. Her laboratory also investigates the basic mechanisms of cellular responses to viral infection in the brain and their relevance to neurodevelopmental disorders. Dr. Gotoh has made significant contributions to understanding: The role of Polycomb group proteins in neural development How chromatin modifiers regulate neurogenic potential Cell cycle regulation in neural stem cells The PDK1-Akt pathway in neuronal migration Layer-specific heterogeneity of astrocytes Mechanisms underlying schizophrenia-related abnormalities Dr. Gotoh's laboratory conducts research on multiple fronts related to neural development and stem cell biology. Her team investigates: Mechanisms regulating neural stem-progenitor cell fate during neocortical development Genetic and epigenetic regulation of neuronal activation The embryonic origin of adult neural stem cells Dysregulation of neural stem-progenitor cell and neuronal fate in neurodevelopmental disorders Innate immune responses in the brain
Erwin Schoof is an Associate Professor at the Department of Biotechnology and Biomedicine , Technical University of Denmark. He leads the Cell Diversity Lab and focuses on advancing proteomics and mass spectrometry technologies. Expertise in single-cell proteomics , stem cell niches , and bioinformatics . Active in myelofibrosis and leukemia research , with applications in UN Sustainable Development Goals . Research Trends from 2025–2024 include: Machine learning-driven peptide sequencing (InstaNovo, InstaNexus). Single-cell resolution tools for mapping hematopoietic stem cells and tumor microenvironments . Biomarker discovery in chronic diseases and respiratory conditions . Supervision : Mentors multiple PhD students on single-cell proteomics , omics data analysis , and biotherapeutic production . Labs & Collaborations : Collaborates with international teams on plasma proteomics , 3D bioengineering , and advanced mass spectrometry workflows .
Professor Guillermo Montoya is a Research Director and Group Leader at the Protein Structure & Function Program of the Novo Nordisk Foundation Center for Protein Research (CPR), University of Copenhagen, Denmark. His work focuses on unraveling cellular mechanisms at the atomic level through advanced methodologies including X-ray crystallography and cryo-electron microscopy. PhD in Chemistry, University of Zaragoza (1989–1993) MSc in Biochemistry, University of the Basque Country (1984–1989) Montoya's research spans Structural Molecular Biology and Genome Integrity , with specific emphasis on: Activation mechanisms of oligomeric kinases CRISPR-Cas12a conformational dynamics Macromolecular complexes in telomere maintenance His publications reveal significant contributions to CRISPR-Cas systems , kinase activation , and DNA/RNA degradation mechanisms . Scientific Awards: EMBO Member (2018) Spanish National Prize in Biomedicine (2009) Multiple Fellowships (EMBO, Marie Curie, FEBS, Marie Curie) Montoya's group integrates structural biology with cell biology to address fundamental questions in genome stability and biomedical applications. His work has been cited over 188 times for studies on CRISPR-Cas endonucleases and has attracted attention from 41 patents.
Hans H. Wandall is Professor and Deputy Head of Department at the University of Copenhagen's Department of Cellular and Molecular Medicine, Faculty of Health Sciences. He serves as Group Leader and Vice-Director of the Copenhagen Center for Glycomics. His educational background includes a PhD in Glycobiology (2004), medical licensure (2001), and MD from University of Copenhagen (1999). Research focuses on glycobiology using gene editing and tissue models to understand glycan functions in: Tissue development and cancer biology Host-virus interactions (HSV-1, Ebola) Stem cell regulation and regenerative medicine Glycan-based therapeutic development Recent publications demonstrate interdisciplinary approaches combining glycoproteomics, virology, and cancer biology, with emphasis on O-glycosylation mechanisms and viral pathogenesis. Awards & Recognition: ERC Consolidator Grant (2017) Lundbeck Foundation Ascending Investigator (2019) Sapere Aude Research Leader Award (2012) Young Scientist Award (2003) Leads multiple funded projects from Lundbeck Foundation, Novo Nordisk Foundation, and Danish National Research Foundation. Supervises doctoral candidates and postdoctoral researchers while directing the GlycoMedicine research group. Founded biotech ventures including GO-Therapeutics and Hemab ApS.
Ole Nørregaard Jensen is a Professor in Biomedical Mass Spectrometry and Systems Biology at the Department of Biochemistry and Molecular Biology, University of Southern Denmark . His research integrates advanced mass spectrometry, proteomics, and bioinformatics to study chromatin biology, post-translational modifications, and cellular signaling networks. He is actively involved in major research initiatives funded by Novo Nordisk Foundation and Lundbeck Foundation. His research interests include Mass Spectrometry, Proteomics, Posttranslational Modification, Histone Biology, Chromatin Biology, Bioinformatics, Systems Biology, Lipidomics, and Protein Chemistry . He employs cutting-edge techniques such as tandem mass spectrometry and ion mobility spectrometry to analyze protein isomers and dynamic modifications. His work has significant implications for understanding gene regulation, DNA replication, and disease mechanisms. His recent publications demonstrate a strong trend in chromatin dynamics, epigenetics, and integrated omics approaches , combining proteomics with transcriptomics and lipidomics to unravel complex biological systems. His research spans from fundamental molecular mechanisms to translational applications in biomedicine and food science. He has been recognized with several prestigious awards: MCP Lectureship Award Juan Pablo Albar Proteomics Pioneer Award 2019 EliteForsk 2009 prize Knight Order of Dannebrog (Ridder af Dannebrogordenen) Jensen is deeply involved in academic service, including peer review for journals like Nature Communications and Molecular and Cellular Proteomics , organizing conferences, and supervising students. He teaches courses such as Biomedical Mass Spectrometry - Principles and Applications and coordinates the Computational Biomedicine international Master’s program. He leads multiple active research projects, including PLATO and INTEGRA, focusing on health data, imaging, and protein networks. He is a key member of a vibrant research environment in biomedical mass spectrometry at SDU, contributing to both national and international scientific collaborations. His lab is at the forefront of developing and applying novel mass spectrometry methodologies for systems biology.
Vijay Tiwari is a Professor in the Department of Molecular Medicine at the University of Southern Denmark (SDU), where he leads research in genome biology and epigenetics. He is affiliated with the Genome Biology VIP initiative and the Danish Institute for Advanced Study (DIAS), highlighting his role in interdisciplinary and high-impact scientific inquiry. His research focuses on epigenetic regulation of gene expression, particularly in the context of cancer and neuroimmunological disorders. Key areas include transcription factor dynamics, locus control regions, promoter regulation, and the role of epigenetic mechanisms in metastasis and immune responses in the central nervous system. The recent publications demonstrate a strong trend in single-cell omics, cancer immunology, and neurodegenerative disease modeling. His work bridges molecular biology with clinical applications, particularly in understanding cancer progression and regenerative failure in ageing. Articles frequently appear in high-impact journals such as Nature Communications , Cancer Research , and Molecular Cancer . Vijay Tiwari’s scientific contributions have received significant media attention, with multiple press releases from SDU highlighting breakthroughs in cancer research, including discoveries that may halt cancer spread. His work has been covered by numerous news outlets, blogs, and social media platforms, indicating broad scientific and public impact. He has advised several early-career researchers, including Inayatullah M. and Dwivedi A.K., who appear as co-authors on multiple publications. While specific grants are not listed, his consistent output and institutional affiliations suggest active funding and collaboration networks across Europe and globally. He is associated with research teams focused on genome biology and epigenetic regulation, likely operating within collaborative labs at SDU that integrate molecular, computational, and clinical approaches to biomedical research.
Lars Aagaard is an Associate Professor at the Department of Biomedicine - Research and Education, Aarhus University, Denmark. He is based at the Bartholin Building in Aarhus C and is actively engaged in research and teaching in the fields of gene therapy, RNA interference, and genome editing. His work focuses on developing viral vectors, particularly AAV and lentiviral vectors, for ocular gene therapy targeting retinal diseases such as age-related macular degeneration and diabetic retinopathy. His research interests include the development of Dicer-independent RNAi systems, combinatorial gene therapy using microRNA and CRISPR/Cas9, and the delivery of RNA- and protein-based therapeutics. He also teaches Genetics and Personalized Medicine and supervises postdoctoral researchers, PhD, master's, and undergraduate students. The recent publications (2022–2024) reflect a strong trend in RNAi therapeutics, viral vector engineering, and translational applications in ocular and systemic diseases. Themes include gene silencing, immune modulation, and regenerative approaches using engineered cells. Aagaard actively contributes to the scientific community as a reviewer for journals such as Nature and Molecular Therapy . He has participated in key international conferences including ARVO, ASGCT, and ESGCT, demonstrating ongoing engagement with the global gene therapy community. Supervision of postdocs, PhD, master’s, and undergraduate students Active participation in international conferences and workshops Collaborative research across institutions, including Universidade Federal de Sao Paulo He is involved in both basic and translational research, with potential for clinical applications in gene and cell therapy.
Bernhard Palsson is the Scientific Director at the Novo Nordisk Foundation Center for Biosustainability (DTU Biosustain), Technical University of Denmark (DTU). His research focuses on systems biology, metabolic engineering, and computational modeling in microorganisms such as Escherichia coli and Yarrowia lipolytica . Key roles : Scientific Director, Researcher, PhD Supervisor SDG contributions : Biosustainability, Antibiotic Discovery, Climate Action Research Interests : Palsson's work spans metabolic pathways , regulatory networks , and genome-scale modeling . He explores chemical stress tolerance mechanisms, pangenome structures, and integrates machine learning with transcriptomic data to advance biosynthetic applications. His projects include antibiotic discovery via computational resources and metabolic model reconstruction for Lactobacillus and Escherichia coli species. Recent Article Trends : His 2025 submissions highlight interdisciplinary approaches combining machine learning and experimental evolution to enhance biochemical production and address antibiotic resistance. Topics include transcriptional network analysis , pangenome decomposition , and metabologenomic modeling , emphasizing scalability and data-driven methodologies. Supervision & Collaboration : Palsson mentors PhD students like Omid Ardalani and collaborates on projects such as iimena (Integration of Informatics and Metabolic Engineering for Novel Antibiotics) and pangenome metabolic model reconstruction. His team includes researchers from DTU and international institutions. Projects : iimena: Novel Antibiotic Discovery (2017–2023) Lactobacillus Pangenome Modeling (2021–2025) Networks : Collaborated with institutions in 12+ countries Co-authorships in Escherichia coli and Yarrowia lipolytica studies
Ala Trusina is an Associate Professor at the Niels Bohr Institute , University of Copenhagen , specializing in Biocomplexity and Biophysics . Her research integrates coarse-grained modeling to study complex biological systems. Key Research Areas Stress Response Systems (diabetes, aging, cancer, inflammation) Stem Cell Differentiation (cell fate coordination, reversibility of states) Complex Systems (species coexistence, epidemics, CRISPR-phage interactions) Methodologies Theoretical: Agent-based modeling, in-silico simulations Experimental: Quantitative single-cell imaging, RNA/protein profiling Collaborations Joshua Brickman (ES cells), Anne Grapin-Botton (pancreas), Feroz Papa (diabetes), Else Kai Hoffman (p53 dynamics) Thomas Mandrup-Poulsen (inflammation), Savas Tay (spatio-temporal regulation) Teaching Physics of Molecular Diseases Numerical Methods in Physics
Manfred Laubichler is President’s Professor of Theoretical Biology and History of Biology at Arizona State University (ASU), where he serves as Director of the School of Complex Adaptive Systems and the Global Biosocial Complexity Initiative. He is also an External Professor at the Santa Fe Institute (SFI) and co-director of the ASU-SFI Center for Biosocial Complex Systems. His academic affiliations include the Center for Social Dynamics and Complexity, the Center for Biology and Society, the Center for Evolution and Medicine, and the Water Institute at ASU. His educational background spans zoology, philosophy, and mathematics from the University of Vienna; biology from Yale University; and history/history of science from Princeton University. Laubichler's research centers on evolutionary novelties across scales—from genomes to knowledge systems—alongside the structure of evolutionary theory and the evolution of scientific knowledge. His work bridges theoretical biology, philosophy of science, and complex systems, with a strong emphasis on biosocial complexity and sustainability. He has contributed extensively to understanding the conceptual foundations of evolutionary developmental biology (Evo-Devo) and the historical and philosophical dimensions of biological theory. His recent publications reflect an interdisciplinary trend, integrating epidemiology, public health, and social behavior during crises such as the COVID-19 pandemic, while maintaining a core focus on theoretical biology, history of science, and complex systems. Themes include trust, scientific responsibility, epistemology of science, and modeling biosocial dynamics. Elected Fellow of the American Association for the Advancement of Science Fellow at the Wissenschaftskolleg zu Berlin Vice Chair of the Global Climate Forum Laubichler has led multiple NSF-funded research initiatives in digital humanities, history and philosophy of science, and complex adaptive systems. He has advised numerous doctoral projects and co-led training programs such as the Embryo Project. He is actively involved in interdisciplinary labs and centers, including the Information and Competition Lab, Complexity Economics Lab, and the Social Insect Research Group. His leadership extends to editorial roles in journals like Biological Theory , Journal of Experimental Zoology Part B , and the Archimedes series.
